Abstract:BackgroundDrug-target interaction (DTI) is a vital drug design strategy that plays a significant role in many processes of complex diseases and cellular events. In the face of challenges such as extensive protein data and experimental costs, it is suggested to apply bioinformatics approaches to exploit potential interactions to design new targeted medications. Different data and interaction types bring difficulties to study involving incompatible and heterology formats. The analysis of drug-target interactions in a comprehensive and unified model is a significant challenge.MethodHere, we propose a general method for predicting interactions between small-molecule drugs and protein targets, Large-scale Drug target Screening Convolutional Neural Network (LDS-CNN), which used unified encoding to achieve the calculation of the different data formats in an integrated model to realize feature abstraction and potential object prediction.ResultOn 898,412 interaction data involving 1683 small-molecule compounds and 14,350 human proteins from 8.8 billion records, the proposed method achieved an area under the curve (AUC) of 0.96, an area under the precision-recall curve (AUPRC) of 0.95, and an accuracy of 90.13%. The experimental results illustrated that the proposed method attained high accuracy on the test set, indicating its high predictive ability in drug-target interaction prediction. LDS-CNN is effective for the prediction of large-scale datasets and datasets composed of data with different formats.ConclusionIn this study, we propose a DTI prediction method to solve the problems of unified encoding of large-scale data in multiple formats. It provides a feasible way to efficiently abstract the features among different types of drug-related data, thus reducing experimental costs and time consumption. The proposed method can be used to identify potential drug targets and candidates for the treatment of complex diseases. This work provides a reference for DTI to process large-scale data and different formats with deep learning methods and provides certain suggestions for future research.

Deep Learning-Based Construction of a Drug-Like Compound Database and Its Application in Virtual Screening of HsDHODH Inhibitors

Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening

Deep Learning in Virtual Screening: Recent Applications and Developments

Development of Ligand-based Big Data Deep Neural Network Models for Virtual Screening of Large Compound Libraries.

Deep Learning and Virtual Drug Screening

Advancing Drug Discovery with Deep Learning: Harnessing Reinforcement Learning and One-Shot Learning for Molecular Design in Low-Data Situations

Restoration of miR-30a expression inhibits growth, tumorigenicity of medulloblastoma cells accompanied by autophagy inhibition.

A deep learning method for drug-target affinity prediction based on sequence interaction information mining

Efficient Exploration of Chemical Space with Docking and Deep Learning

A compact review of progress and prospects of deep learning in drug discovery

Deep Learning Based Drug Metabolites Prediction

Application of Deep Learning Neural Networks in Computer-aided Drug Discovery: A Review

DeepDrug: A General Graph-Based Deep Learning Framework for Drug-Drug Interactions and Drug-Target Interactions Prediction

LDS-CNN: a deep learning framework for drug-target interactions prediction based on large-scale drug screening

On Modeling and Utilizing Chemical Compound Information with Deep Learning Technologies: A Task-oriented Approach

Deep Learning Methods for Small Molecule Drug Discovery: A Survey

Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases

Structure-Based Drug Design with a Deep Hierarchical Generative Model

DeepH-DTA: Deep Learning for Predicting Drug-Target Interactions: A Case Study of COVID-19 Drug Repurposing

Compound–protein interaction prediction by deep learning: Databases, descriptors and models

De Novo Generation and Identification of Novel Compounds with Drug Efficacy Based on Machine Learning